NCT01649947 Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II Status COMPLETED Phase PHASE2
NCT01646450 First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients Status UNKNOWN Phase PHASE4
NCT01640847 MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases Status WITHDRAWN Phase PHASE2
NCT01639508 Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity Status RECRUITING Phase PHASE2
NCT01635270 Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma Status COMPLETED Phase PHASE2
NCT01631552 Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01631357 Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01630733 A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01630122 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates Status COMPLETED Phase N/A
NCT01625234 Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01619241 Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer Status UNKNOWN Phase N/A
NCT01617980 Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer Status TERMINATED Phase NA
NCT01610336 A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment Status COMPLETED Phase PHASE2
NCT01607554 Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01605916 Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01598597 An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) Status COMPLETED Phase N/A
NCT01597258 Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01593293 Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT01574729 Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma Status UNKNOWN Phase PHASE2